College of Psychiatric and Neurologic Pharmacists Releases 2013 Residency Director Survey Results

The College of Psychiatric and Neurologic Pharmacists has released the 2013 Residency Program Director Survey results. Every year, the Resident and New Practitioner Committee asks all Residency Directors with a residency program listed on cpnp.org to complete a brief survey. The purpose of this survey is to gather information which will assist the committee and CPNP in:

  1. Increasing the visibility of postgraduate training in psychiatric/neurologic pharmacy.
  2. Increasing the number of psychiatric/neurologic pharmacy specialists completing postgraduate training.
  3. Increasing the involvement and participation of residency program directors, trainees, and new practitioners in CPNP.

Below is a brief summary of 2013 survey findings:

  • 43of 64 programs responded (67% response rate).
  • Majority of programs offer 1 or more PGY2 psychiatric pharmacy slots and 4 programs offer a combined PGY1/PGY2 residency program.
  • Over 95% of programs are ASHP accredited or are seeking ASHP accreditation. The most common reason for not obtaining ASHP accreditation includes financial concerns.
  • The VA or University teaching hospitals serve as the primary practice site for 73% of programs.
  • The majority of programs (81%) filled their residency slots for 2013-2014. Over 28% utilized ASHP’s pre-commitment process and 27% participated in the post-match scramble.
  • The majority of programs offered a mixture of inpatient and outpatient settings (60%), followed by primarily inpatient programs (28%).
  • For 2012-2013, the majority of residents (69%) obtained positions upon completion of their residency program. Over one half (52%) of residents acquired positions at the VAMC and in Community Hospital practice settings with one third obtaining a position as a psychiatric or neurologic clinical specialist.
  • The attributes considered most valuable when hiring new employees included a PGY2 psychiatric pharmacy residency and the Board Certified Psychiatric Pharmacist (BCPP) credentials or plans to obtain the BCPP.

You can view the full survey results or a summary of the results.

About CPNP

The College of Psychiatric and Neurologic Pharmacists (CPNP) is a professional association of over 1300 members dedicated to promoting excellence in pharmacy practice, education and research to optimize treatment outcomes of individuals affected by psychiatric and neurologic disorders. Members of CPNP are pharmacists who work directly with patients and caregivers to apply specialized clinical knowledge and skills, educate and train healthcare professionals and develop new knowledge in order to improve health outcomes for those individuals with psychiatric and neurologic disorders. Members apply evidence-based, cost-efficient best practices as a member of a treatment team to achieve patient recovery and improved quality of life.

CPNP actively partners with the National Alliance on Mental Illness (NAMI) and health care associations recognizing the importance of consumers, pharmacists and other specialized professionals working together in managing psychiatric illness. CPNP is integrally involved in supporting and providing educational products and services such as the CPNP Annual Meeting and recertification education for the 700+ Board Certified Psychiatric Pharmacists (BCPPs), 75% of whom are members of CPNP.